HIST1H2BE | Histone cluster 1, H2be | Plasma proteins
| | | | | Mixed |
HIST1H2BF | Histone cluster 1, H2bf | Plasma proteins
| | | | | Tissue enhanced |
HIST1H2BG | Histone cluster 1, H2bg | Plasma proteins
| | | | | Mixed |
HIST1H2AE | Histone cluster 1, H2ae | | | | | | Tissue enhanced |
HIST1H3F | Histone cluster 1, H3f | | | | | | Tissue enhanced |
HIST1H2BH | Histone cluster 1, H2bh | | | | | | Tissue enhanced |
HIST1H2BI | Histone cluster 1, H2bi | Plasma proteins
| | | | | Tissue enhanced |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ZNF322 | Zinc finger protein 322 | Transcription factors
| | | | | Mixed |
HIST1H2BJ | Histone cluster 1, H2bj | | | | | | Tissue enhanced |
HIST1H2BK | Histone cluster 1, H2bk | | | | | | Expressed in all |
HIST1H2AH | Histone cluster 1, H2ah | | | | | | Tissue enriched |
HIST1H2BL | Histone cluster 1, H2bl | Plasma proteins
| | | | | Tissue enriched |
HIST1H3H | Histone cluster 1, H3h | | | | | | Tissue enhanced |
HIST1H2BM | Histone cluster 1, H2bm | | | | | | Tissue enhanced |
HIST1H2BN | Histone cluster 1, H2bn | | | | | | Mixed |
HIST1H2BO | Histone cluster 1, H2bo | | | | | | Tissue enhanced |
ZSCAN16 | Zinc finger and SCAN domain containing 16 | Transcription factors
| | | | | Expressed in all |
ZSCAN31 | Zinc finger and SCAN domain containing 31 | Transcription factors
| | | | | Expressed in all |
TRIM27 | Tripartite motif containing 27 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MOG | Myelin oligodendrocyte glycoprotein | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HLA-G | Major histocompatibility complex, class I, G | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TRIM26 | Tripartite motif containing 26 | | | | | | Expressed in all |
HLA-E | Major histocompatibility complex, class I, E | Predicted membrane proteins
| | | | | Expressed in all |
PPP1R10 | Protein phosphatase 1, regulatory subunit 10 | | | | | | Expressed in all |
MRPS18B | Mitochondrial ribosomal protein S18B | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
DHX16 | DEAH (Asp-Glu-Ala-His) box polypeptide 16 | Enzymes
| | | | | Expressed in all |
PPP1R18 | Protein phosphatase 1, regulatory subunit 18 | Cytoskeleton related proteins
| | | | | Expressed in all |
MDC1 | Mediator of DNA-damage checkpoint 1 | Cancer-related genes
| | | | | Expressed in all |
TUBB | Tubulin, beta class I | Cytoskeleton related proteins FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FLOT1 | Flotillin 1 | Plasma proteins
| | | | | Expressed in all |
DPCR1 | Diffuse panbronchiolitis critical region 1 | Predicted membrane proteins
| | | | | Tissue enriched |
CDSN | Corneodesmosin | Predicted secreted proteins
| | | | | Tissue enriched |
POU5F1 | POU class 5 homeobox 1 | Cancer-related genes Transcription factors
| | | | | Mixed |
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | | | | | | Tissue enriched |
LTB | Lymphotoxin beta (TNF superfamily, member 3) | Cancer-related genes Plasma proteins
| | | | | Group enriched |
AIF1 | Allograft inflammatory factor 1 | | | | | | Expressed in all |
BAG6 | BCL2-associated athanogene 6 | | | | | | Expressed in all |
APOM | Apolipoprotein M | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CSNK2B | Casein kinase 2, beta polypeptide | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
LY6G6D | Lymphocyte antigen 6 complex, locus G6D | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLIC1 | Chloride intracellular channel 1 | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
VARS | Valyl-tRNA synthetase | Enzymes Plasma proteins
| | | | | Expressed in all |
HSPA1L | Heat shock 70kDa protein 1-like | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
HSPA1A | Heat shock 70kDa protein 1A | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
SLC44A4 | Solute carrier family 44, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
EHMT2 | Euchromatic histone-lysine N-methyltransferase 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CFB | Complement factor B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |